WO1998048863A1 - Sonde a ballonnet - Google Patents
Sonde a ballonnet Download PDFInfo
- Publication number
- WO1998048863A1 WO1998048863A1 PCT/JP1998/001838 JP9801838W WO9848863A1 WO 1998048863 A1 WO1998048863 A1 WO 1998048863A1 JP 9801838 W JP9801838 W JP 9801838W WO 9848863 A1 WO9848863 A1 WO 9848863A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- balloon
- ethylene
- catheter
- catalyst
- polymerized
- Prior art date
Links
- 229920000098 polyolefin Polymers 0.000 claims abstract description 40
- 239000012968 metallocene catalyst Substances 0.000 claims abstract description 25
- 238000002844 melting Methods 0.000 claims description 29
- 230000008018 melting Effects 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 24
- 239000003054 catalyst Substances 0.000 claims description 22
- 229920000089 Cyclic olefin copolymer Polymers 0.000 claims description 20
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 18
- 239000005977 Ethylene Substances 0.000 claims description 18
- 239000002861 polymer material Substances 0.000 claims description 14
- 229920001577 copolymer Polymers 0.000 claims description 11
- -1 polyethylene Polymers 0.000 claims description 10
- 229920013716 polyethylene resin Polymers 0.000 claims description 10
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 150000001336 alkenes Chemical class 0.000 claims 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 1
- 229920005606 polypropylene copolymer Polymers 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 23
- 238000006116 polymerization reaction Methods 0.000 abstract description 7
- 210000004204 blood vessel Anatomy 0.000 description 15
- 238000000465 moulding Methods 0.000 description 14
- 230000014759 maintenance of location Effects 0.000 description 13
- 229920005989 resin Polymers 0.000 description 12
- 239000011347 resin Substances 0.000 description 12
- 239000004711 α-olefin Substances 0.000 description 11
- 229920001684 low density polyethylene Polymers 0.000 description 10
- 239000004702 low-density polyethylene Substances 0.000 description 10
- 229920001971 elastomer Polymers 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 230000000704 physical effect Effects 0.000 description 6
- 241000446313 Lamella Species 0.000 description 5
- 239000000806 elastomer Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000000071 blow moulding Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- KWKAKUADMBZCLK-UHFFFAOYSA-N methyl heptene Natural products CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000024883 vasodilation Effects 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N 1-Heptene Chemical compound CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- SUWJESCICIOQHO-UHFFFAOYSA-N 4-methylhex-1-ene Chemical compound CCC(C)CC=C SUWJESCICIOQHO-UHFFFAOYSA-N 0.000 description 2
- 201000000057 Coronary Stenosis Diseases 0.000 description 2
- 206010011089 Coronary artery stenosis Diseases 0.000 description 2
- 206010016322 Feeling abnormal Diseases 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 206010053648 Vascular occlusion Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003426 co-catalyst Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 229920000092 linear low density polyethylene Polymers 0.000 description 2
- 239000004707 linear low-density polyethylene Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 229920001225 polyester resin Polymers 0.000 description 2
- 229920005678 polyethylene based resin Polymers 0.000 description 2
- 229920005990 polystyrene resin Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 230000002966 stenotic effect Effects 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 208000021331 vascular occlusion disease Diseases 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- ZOICEQJZAWJHSI-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenyl)boron Chemical compound [B]C1=C(F)C(F)=C(F)C(F)=C1F ZOICEQJZAWJHSI-UHFFFAOYSA-N 0.000 description 1
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 1
- KLCNJIQZXOQYTE-UHFFFAOYSA-N 4,4-dimethylpent-1-ene Chemical compound CC(C)(C)CC=C KLCNJIQZXOQYTE-UHFFFAOYSA-N 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229920000181 Ethylene propylene rubber Polymers 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 125000005595 acetylacetonate group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003484 crystal nucleating agent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 229920005648 ethylene methacrylic acid copolymer Polymers 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 229920003049 isoprene rubber Polymers 0.000 description 1
- 239000011980 kaminsky catalyst Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000006078 metal deactivator Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000012785 packaging film Substances 0.000 description 1
- 229920006280 packaging film Polymers 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011527 polyurethane coating Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000007613 slurry method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229920001862 ultra low molecular weight polyethylene Polymers 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/04—Homopolymers or copolymers of ethene
- C08L23/08—Copolymers of ethene
- C08L23/0807—Copolymers of ethene with unsaturated hydrocarbons only containing four or more carbon atoms
- C08L23/0815—Copolymers of ethene with unsaturated hydrocarbons only containing four or more carbon atoms with aliphatic 1-olefins containing one carbon-to-carbon double bond
Definitions
- the present invention relates to balloon catheters, and more particularly, to high strength, high flexibility, moldability, shapeability, shape retention, safety, fusion to catheters.
- the present invention relates to a balloon catheter having a balloon with excellent properties.
- the balloon catheter of the present invention is particularly suitable as a balloon balloon for expansion for expanding a living organ such as a blood vessel or a body cavity. Background technology>
- the banana tube (ba11oon—tipcatheter) is a tube with a balloon attached to the tip. After insertion into a body cavity, the tube can be expanded or degassed without being removed. It is possible to do so.
- the balloon When the balloon is introduced into the blood vessel and the balloon is inflated, the inflated balloon is propelled by the blood flow, so that the catheter can easily pass through the blood vessel.
- the balloon When the balloon is degassed, the blood vessels through which blood flows freely can be closed by inflating the balloon.
- the balloon catheter is used for, for example, 1 arterial occlusion ⁇ thrombus removal, 2 venous thrombus removal, 3 stenotic artery dilatation, 4 vascular occlusion ⁇ vascular occlusion, 5 removal of foreign matter in blood vessels, etc.
- it is classified into, for example, an arterial thrombus removal balloon catheter, an occlusion balloon catheter, and a vasodilation balloon catheter.
- a balloon balloon for expansion has a structure in which a balloon 2 is arranged near the tip of a catheter 1 as shown in FIG. Through the opening provided in the catheter 1, the nozzle 2 can inflate and inflate the air, or can deflate it by degassing.
- the catheter 1 is usually equipped with various parts such as a side-arm adapter 13 and an adapter 4.
- a sheath that connects between the outside of the body and the blood vessel using a vascular puncture device called a sheath introducer and serves as a catheter passageway Into a blood vessel, and then a thin catheter into the blood vessel.
- a pressure-resistant dilatation balloon catheter is inserted into the stenosis, and the balloon is inflated to press the thickened intima, which has undergone atherosclerosis, against the adventitia, thereby forming a lumen. It is expanding. This method is called percutaneous arterial luminal dilatation and has good results.
- stenosis of coronary arteries and the like is often treated by vasodilation using a vascular dilatation catheter instead of coronary artery bypass surgery.
- a vascular dilatation catheter instead of coronary artery bypass surgery.
- Balun catheters for dilatation include, for example, 1) the ability to treat peripheral coronary artery stenosis, 2) easy insertion into flexed blood vessels, 3) strong dilatation pressure, and 4) safe vascular expansion. It must be able to be extended.
- a vascular dilatation balloon catheter be used to treat peripheral coronary artery stenosis more than before. For this purpose, it is necessary to reduce the profile of the balloon (reducing the projected area in the longitudinal direction), and a thinner and stronger balloon is required.
- a balloon catheter for dilatation is inserted into a bent blood vessel. However, in order to facilitate insertion into a bent blood vessel, the needle is made flexible and trapped. It is required that there be certain strengths.
- a vascular dilatation can be performed safely using a balloon balloon for dilatation. It is required that the pri- ority (that is, the rate of change of the balloon expansion diameter with respect to the balloon expansion pressure) be within an appropriate range and that the breaking strength be high.
- a polyethylene resin As a material for a balloon catheter for expansion, a polyethylene resin has been mainly used because of its relatively good balance between processability and physical properties. I have. However, as the required level of properties of the balloon balloon for expansion has become higher, there has been a problem that conventional polyethylene resins cannot sufficiently cope with the problem.
- Conventional balloons made of low-density polyethylene (LDPE) have insufficient strength and flexibility. Even if linear low-density polyethylene (LLDPE) is used in place of LDPE, the effect of improving strength is small, and only balloons with poor flexibility can be obtained. Even if a balloon made of polyethylene resin is crosslinked by electron beam crosslinking, moisture crosslinking, etc. It is not possible to obtain an excellent balance in terms of flexibility, compliance at the time of balloon expansion, and the like.
- the balloon balloon for expansion is shaped into a fixed shape wrapped around the catheter in order to facilitate insertion and removal into and out of a body cavity such as a blood vessel, and is held in that shape during decompression. This is often the case.
- the conventional balloon made of polyethylene resin is not sufficient in shapeability and shape retention. Balloons using a polyamide-based resin / polyester-based resin are also known, but it is difficult to obtain a balloon having excellent balance between strength and compliance.
- an object of the present invention to provide high strength, excellent flexibility, easy formation of a folded balloon, good setting, and compliance within a proper range when the balloon is expanded.
- an object of the present invention is to provide a balloon catheter having a balloon excellent in moldability, shape retention, and fusion bonding to a catheter.
- a polyolefin that has been polymerized using a metal oxide catalyst is used as a balloon forming material. It has been found that by using such a device, a normal catheter having good characteristics can be obtained. In addition, by selecting and using an ethylene-one-year-old refine copolymer having specific physical properties as a polirefin, the high required characteristics as described above can be obtained. Can be fully satisfied, especially as an expansion balloon catheter. It has been found that a suitable balloon catheter can be obtained.
- the present inventors studied whether or not a polyrefin produced using a metallocene catalyst is suitable as a balloon forming material for a balloon balloon for expansion.
- LDPE low-density polyethylene
- LLDPE linear low-density polyethylene
- a ball with a better balance of various properties such as shapeability, shape retention, flexibility, and breaking strength can be obtained.
- the polymer material forming the balloon is formed by a metallocene catalyst.
- the present invention provides a balloon catheter characterized in that the balloon catheter contains a polyolefin polymerized using the above method.
- FIG. 1 is a schematic diagram showing an example of an expansion balloon catheter.
- a polymer material containing a polyolefin produced by a polymerization reaction using a metal oxide catalyst is used as a balloon forming material of a balloon balloon for expansion.
- a metallocene catalyst (also known as a Kaminsky catalyst or a single-site catalyst) is a metallocene compound having a structure in which a transition metal is sandwiched between electronically unsaturated compounds. Used in combination with co-catalysts such as oxane and organic aluminum compounds.
- metasynthetic compounds include transition metals of Group IVA such as zirconium, titanium, and phenol, (substituted) cyclopentagenenyl, (substituted) indenyl, and (substituted) One or two of the tetrahydroidenyl and (substituted) fluorenyl groups are bonded, or two of these groups are covalently cross-linked to form a bond.
- the co-catalyst is an ionizable compound or an electrophilic compound formed from an ion pair of cation and anion, and reacts with a meta-sene compound to form a stable ion.
- compounds that form polymerization-active species for example, tetrakis (pentafluorophenyl) boron, etc. can be used.
- Monomers for polymerizing polyolefins include ethylene, propylene, 1-butene, 11-pentene, 11-hexene, and 1-octane. Ten, 11-heptene, 4-methyl-1—pentene, 4-methyl-1—hexene, 4,4-dimethyl-1—pentene, and the like. Each of these monomers can be used alone or in combination of two or more.
- polyethylene and ethylene-polyolefin copolymers are preferred from the viewpoint of various properties as a catalyst.
- an ethylene- ⁇ -olefin copolymer is particularly preferred.
- the ethylene / ⁇ -olefin copolymer can be obtained by copolymerizing ethylene and polyolefin using a metallocene catalyst. You.
- a comonomer it is preferable to use a monorefin having 4 to 40 carbon atoms.
- the copolymerization ratio of the aged refin is usually 2 to 50% by weight, preferably 5 to 40% by weight, more preferably 10 to 40% by weight. ⁇ 30% by weight.
- Examples of the (co) polymerization method of polyolefin using a metallocene catalyst include a gas phase method, a solution method, a bulk polymerization method, a high pressure method, and a slurry method.
- the polymerization conditions are usually a polymerization temperature of —100 to 250 ° C., a polymerization time of 5 minutes to 10 hours, and a reaction pressure of normal pressure to SOOkgZcm. It is.
- Molelet-to-mouth rate of polyolefins such as ethylene- ⁇ -olefin copolymers polymerized using metal-opened catalysts (MFR; JISK — 7210) ) Is usually 0.1 to 30.0 g / 10 minutes, preferably 1.0 to 20.0 g / 10 minutes, and more preferably 1.0 to 15.0. g / 10 minutes, most preferably 1.5 to: 15.0 g / 10 minutes. If the MFR is too small, it is difficult to obtain sufficient strength, and if the MFR is too large, the moldability decreases. Po Riorefi down density...
- JISK - 7 1 1 2 is usually at 0 9 5 0 g / cm 3 or less, 0 and rather the preferred 8 5 0 ⁇ 0 9 4 0 g Z cm 3, Ri and rather is preferred is 0. 8 8 0 ⁇ 0. 9 3 0 g / cm 3. If the density is too low, problems such as blocking due to stickiness of the balloon surface are likely to occur, and if it is too high, transparency is reduced.
- Polyolefins polymerized using a metallocene catalyst use a metallocene catalyst having a uniform active site, and thus have not only a narrow molecular weight distribution, but also ethylene-hydrogen.
- the composition distribution is narrowed by the fact that the mono-monoolefin, which is a comonomer, enters the main chain of ethylene uniformly. . Therefore, low-molecular-weight, low-density components (solid portions) are small, and components extracted with an organic solvent are small.
- spherulites are formed.
- Lamella (a thin layer like a single crystal) is a structural unit that forms spherulites. Ethylene using a metallocene catalyst Polymers have thin lamellas, while on the other hand, there are many tie molecules that connect lamellas, and these factors result in a strong finolem. Is obtained.
- Polyolefins such as ethylene- ⁇ -olefin copolymers using metallocene catalysts may be synthesized, but many types are already manufactured and sold. Commercial products may be used. However, as mentioned above, changes in physical properties when molding a balloon using a polymer material and how to apply force when using a balloon are extremely complicated. It is desirable to select one that can give particularly excellent ballooning characteristics from among the polymerized polyrefins.
- Polyolefins polymerized using a metallocene catalyst are generally used for various purposes such as density, type and amount of comonomer, and MFR. When used as materials, it is not always appropriate to use these as indicators.
- the present inventors have studied various polymer materials. As a result, when a balloon is formed into a balloon, it is necessary to obtain a balloon having excellent molding workability and various characteristics.
- polyethylene resins such as polyethylene and ethylene- ⁇ -olefin copolymer are preferred. It has been found that Lenn-Hyrefin copolymers are more preferred.
- Result of extensive research of al Po the Rio reflex Lee emissions polymerized using a meta opening Sen catalyst, and 1 2 5 ° C below the melting point, also has a 2 5 0 kcm 2 or more tensile breaking strength It was found that those having a melting point of 120 ° C.
- a tensile breaking strength of 350 kg / cm 2 or more were more preferred.
- it is an ethylene copolymer polymerized using a metallocene catalyst. It is a 1-year-old olefin copolymer with a low melting point of 120 ° C or less and a tensile fracture strength of 350 ° C. 0 kg
- the use of a high-strength material having a strength of / cm 2 or more is most preferable because balloons having remarkably excellent flexibility and breaking strength and excellent shapeability and shape retention can be obtained.
- a polyolefin particularly an ethylene-polyolefin copolymer, which is produced using a metallocene catalyst and has such specific physical properties, is used as a balloon.
- the balloon has high strength, excellent flexibility, and the compliance can be designed within an appropriate range.
- a balun that is easy to wear can be obtained.
- Ethylene ' ⁇ -olefin copolymers have a low melting point and are easy to mold and process into balloons, but there are many tie molecules that connect lamellas. High strength balloon can be obtained.
- Polyolefins such as ethylene and polyolefin copolymers produced using metallocene catalysts must have a difference between melting point and softening point (melting point-softening point) of 15 ° C or more. Is preferred. If a polyolefin having a large difference between the melting point and the softening point and a low softening point is used, when the obtained balloon is folded, the balloon can be easily shaped and the setting property is good. Becomes For example, a balloon balloon for expansion is shaped into a fixed shape wound around a catheter so that it can be easily inserted into and removed from a body cavity such as a blood vessel. It is often held in that fixed shape.
- Low-density polyethylene which is a conventional balloon material, has a low melting point, but a relatively high softening point, and does not always have sufficient shapeability and shape retention.
- Linear low-density polyethylene (LLDPE) polymerized using a conventional multi-site catalyst has a large difference between its melting point and softening point, but has a high melting point and relatively high softening point, so it is shaped. Properties and shape retention are insufficient.
- Polyolefins such as ethylene- ⁇ -olefin copolymers produced using a metallocene catalyzed catalyst have tensile fracture strength ( ⁇ ⁇ ) / tensile yield strength ( ⁇ ) Is preferably 3.0 times or more.
- Polyolefins having such physical properties such as ethylene-polyvinyl olefin copolymers, have higher tensile fractures than conventional polyethylene resins, for example. Since it has a high tensile breaking strength / tensile yield strength ratio as well as breaking strength, it is easy to stretch at the time of forming the balloon, and the effect of stretching is easily obtained.
- Ethylene-Hi-ichisa refin copolymer polymerized using a metal-opened selenium catalyst has a narrow molecular weight distribution and excellent uniform stretchability.
- the stretching is not uniform due to uneven thickness of the tube.
- the ethylene / hydroolefin copolymer having a ratio of tensile fracture strength to tensile yield strength of 3 times or more is extremely low in tensile yield strength as compared with tensile fracture strength, for example, When a balloon is formed by a stretching process, even if the tubular parison has uneven thickness, uniform stretching can be performed over the entire balloon. In addition, the high tensile fracture strength provides a high quality and strong crack run.
- a polyolefin having a high ratio of tensile breaking strength / tensile yield strength such as ethylene-refined olefin copolymer
- compliance balloon expansion
- the rate of change of balloon expansion diameter with respect to the expansion pressure is lower than that of a conventional polyethylene resin, but is larger than that of a polyester resin or a polyamide resin. You can get balloons in the proper range. If the compliance is too large, it will be difficult to dilate the blood vessels safely, and if it is too small, it will be difficult to dilate it efficiently.
- the balun of the present invention has a uniform molecular weight, a small and uniform molecular weight unique to a polyolefin such as an ethylene-hydroolefin copolymer obtained using a metallocene catalyst. Thin spherulite layer (lamella) and the high probability of the presence of the tie molecules connecting these lamellae. You can get a baloon that is not bothersome. On the other hand, when a polymer material having a high molecular chain crystallinity such as a polyamide-based polymer is used, the balloon becomes rigid.
- the polymer material forming the balloon includes a polyolefin polymerized using a metallocene catalyst, and in particular,
- the ratio (TBZTA) of tensile breaking strength (TB) to tensile yield strength (TA) is 3.0 or more
- It is preferably an ethylene / ⁇ -olefin copolymer of the formula (1).
- the melting point of the ethylene-refined olefin copolymer is preferably from 95 to 120. C, more preferably 100 ° C to 120 ° C.
- the range of the softening point is preferably from 70 to: 105 ° C, more preferably from 75 to: L03 ° C.
- the difference between the melting point and the softening point is preferably between 15 and 50 ° C, more preferably between 15 and 45 ° C.
- the tensile breaking strength is favored properly 3 5 0 ⁇ 5 0 0 kg / cm, rather than the preferred Ri good is a 3 5 5 ⁇ 4 5 0 kg / cm 2.
- the ratio (TBZT y) between the tensile breaking strength (TB) and the tensile yield strength (T 7) is preferably 3.0 to 10.0, more preferably 3.5 to 8.0. It is.
- the polymer material for forming balloons is Polyolefin which has been polymerized using a medium, particularly preferably the above-mentioned specific ethylene / polyolefin copolymer can be used alone.
- a medium particularly preferably the above-mentioned specific ethylene / polyolefin copolymer can be used alone.
- Various additives, other resins and elastomers can be blended within a range that does not impair the object of the invention.
- additives for example, it is possible to add several kinds of antioxidants, ultraviolet absorbers, antistatic agents, flame retardants, metal deactivators, pigments, dyes, crystal nucleating agents, etc. as necessary. it can.
- the amount of addition is usually 20 parts by weight or less, preferably 5 parts by weight or less, based on 100 parts by weight of the polyolefin.
- resins include various resins polymerized using a zigzag-catalyzed catalyst, such as polypropylene resins, high-density polyethylene, and linear low-density polystyrene.
- Polyolefin resins such as polymers, ethylene-acrylic acid copolymers, ethylene-methacrylic acid copolymers, ethylene carbon monoxide copolymers, etc .; Amorphous polystyrene resin, crystalline polystyrene resin, polychlorinated vinyl resin, polyamide, polycenter, polyforce-bone, etc.
- the mixing ratio of the other resin is usually 100 parts by weight or less, preferably 100 parts by weight or less, more preferably 3 parts by weight to 100 parts by weight of the polyolefin. 0 parts by
- Elastomers include, for example, ethylene-propylene rubber, ethylene-11-butene rubber, propylene-11-butene rubber, and styrene.
- Solid rubber such as butadiene rubber and its hydrogenated product, isoprene rubber, neoprene rubber, acrylonitrile-butadiene rubber and its hydrogenated product, or styrene-butadiene block Copolymer elastomer Styrene-based thermoplastic elastomers such as hydrogenated products and hydrogenated products thereof, and other various elastomers can be used.
- the mixing ratio of the elastomer is usually 100 parts by weight or less, preferably 50 parts by weight or less, more preferably 100 parts by weight of the polyrefin. Is less than 30 parts by weight.
- the mixing of the other components into the polyolefin is performed by liquid mixing or solid mixing, but generally, melt kneading is used.
- melt kneading is used.
- a kneader such as a roll, a screen, a Banbury mixer, a knee, a blender, and a mill
- each component is kneaded at a desired temperature, and after kneading, it is formed into granules of an appropriate size. Granulate.
- methods such as the strand cut method, the underwater cut method, the hot cut method, the mist cut method, the sheet cut method, the freeze-pulverization method, the melt spray method, etc. Either method may be used.
- a conventional method is used to form a tubular parison and stretch blow-mold it in a mold. Is adopted. Extrusion molding, copper wire coating, etc. are used for tube molding.
- the blow molding temperature is usually about 30 to 180 ° C, preferably about 80 to 120 ° C.
- the longitudinal stretching ratio is preferably at least 130%, and the effective total stretching ratio (tube cross-sectional area / ball cross-sectional area) is preferably at least 5 times. After the stretching process, heat treatment can be performed to prevent large thermal contraction due to the subsequent heat history.
- the tube-shaped parison may be stretched and molded as it is. If desired, irradiate with ionizing radiation such as an electron beam to crosslink and then stretch-blow mold. be able to. By irradiation crosslinking, the pressure resistance of the balloon can be improved.
- the irradiation dose is usually about 2 to 15 MR, and the gel fraction of the tube cross-linked by irradiation is usually 0. It is preferable to set it to about 75-0.95.
- the gel fraction can be measured as the insoluble content of the crosslinked sample in heated xylene, and more specifically, 0.1 g of the crosslinked sample can be measured at 120 ° C. After heating in 100 ml of xylene heated to C for 6 hours, the soluble matter is filtered off, the dry weight of the remaining crosslinked sample is measured, and the ratio to the crosslinked sample before treatment Is calculated.
- the balloon thus obtained may be used as it is, but if desired, another layer such as a polyurethane coating may be laminated.
- the balloon surface can be coated with various natural or synthetic hydrophilic polymers to enhance lubricity in blood or saline.
- a polyolefin polymerized using a metallocene catalyst preferably a specific ethylene ' ⁇ -olefin copolymer, is used as the balloon-forming material. Since a polymer material containing coalesced is used, it is possible to obtain a thin and high-strength balloon with excellent molding processability of balloon. This balloon has good shapeability, shape retention, flexibility, etc., and its compliance is within an appropriate range.
- This balloon also has excellent adhesion to catheters. Therefore, by using this balloon, it is possible to obtain a balloon balloon for dilatation that satisfies the high required characteristics.
- the size of the balloon can be appropriately determined according to the application site.However, in the case of a balloon catheter for vasodilation, the length is usually about 10 to 100 mm and the outer diameter is 2 mm. It is about 10 mm.
- the film thickness of the norun is usually about 5 to 100 m, preferably about 10 to 50 m. However, when applied to peripheral coronary arteries, etc., a low profile can be achieved.
- the balloon catheter of the present invention is a polymer material containing a polyolefin polymerized using a metallocene catalyst near the tip of the catheter. It has a balloon formed from it.
- Figure 1 shows a typical example.
- the material of the catheter include general-purpose polymer materials such as high-density polyethylene, polyvinylidene fluoride, and polyimide.
- a polyolefin that is polymerized using the same sulfuric acid catalyst as in balloon may be used.
- Each resin having the material properties shown in Tables 1 and 2 was used as the balloon forming material, and a raw material tube with an outer diameter of about 1 mm and a wall thickness of 50 m was manufactured by extrusion molding. .
- This raw material tube was cut into a length of 100 mm to obtain a tubular parison.
- This tube-shaped parison is placed in a balloon outer mold having an inner diameter of 4 mm and a length of 30 mm, and the molding temperature is set within a range of 0.5 to 0.8 times the melting point of each resin.
- was set to 8 ⁇ 4 kg / cm 2 blow molding was performed, and radial stretching was applied to form a balloon.
- the balloon formed as described above was fused to a catheter tube (made of polyethylene) having an outer diameter of 1 mm and a wall thickness of 200 m.
- the fusing temperature was adjusted to a melting point of each resin of 0.2 ° C.
- the above-prepared catheter with a balloon is decompressed, and the balloon is wrapped around the circumference of the catheter. Covering was performed at 70 ° C for 1 hour.
- the shape of the balloon during decompression was observed and evaluated according to the following criteria.
- ⁇ The knob is wrapped around the catheter neatly.
- ⁇ The wound shape of the balloon is slightly disturbed.
- the balloon was expanded and decompressed again, and the shape of the balloon was observed and evaluated according to the following criteria.
- ⁇ The knob is wrapped around the catheter neatly.
- the balloon at the time of decompression was pinched with a finger, and the hardness was evaluated according to the following criteria.
- Molding temperature [° C] 80 73 83 80 88 77 Molding pressure [kg / cm 2 ] 6.7 6.1 7.0 6.7 7.2 6.5 Fusing temperature [. c] 112 102 115 112 122 109 Imprinting temperature [° c] 70 70 70 70 70 70 Balloon dimensions
- Tensile fracture strength is the tensile stress at the time of specimen breakage
- tensile yield strength is the stress corresponding to the first point on the load-elongation curve where the increase in elongation is observed without an increase in load.
- the balloon catheter according to the present invention has good balloon characteristics.
- the polymerization using a metal-opened catalyst has a melting point of 120 ° C or less, a tensile breaking strength of 350 kg Zcm 2 or more, a difference between the melting point and the softening point of 15 ° C or more, (Tensile breaking strength Z tensile yield strength)
- Balloons formed by using an ethylene / hi-ichi refin copolymer with a ratio of 3 times or more have excellent shapeability, shape retention, flexibility,
- the fracture strength was remarkably excellent, and the compliance was within an appropriate range, so that the blood vessels could be dilated safely and efficiently. Therefore, the balloon balloon of the present invention is particularly suitable as a balloon balloon for expansion.
- the strength is high, it is excellent in flexibility, it is easy to shape the folded balloon, the setting is good, and the compliance when the balloon is expanded is in an appropriate range.
- a balloon catheter that is suitable as an expansion balloon catheter that has a balloon with excellent moldability, shape retention, and fusion property to the catheter is provided. Is done.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98917617A EP0982040A4 (en) | 1997-04-25 | 1998-04-22 | BALLOON PROBE |
US09/403,481 US6238408B1 (en) | 1997-04-25 | 1998-04-22 | Balloon catheter |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/123591 | 1997-04-25 | ||
JP9123591A JPH10295801A (ja) | 1997-04-25 | 1997-04-25 | バルーンカテーテル |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998048863A1 true WO1998048863A1 (fr) | 1998-11-05 |
Family
ID=14864400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/001838 WO1998048863A1 (fr) | 1997-04-25 | 1998-04-22 | Sonde a ballonnet |
Country Status (4)
Country | Link |
---|---|
US (1) | US6238408B1 (ja) |
EP (1) | EP0982040A4 (ja) |
JP (1) | JPH10295801A (ja) |
WO (1) | WO1998048863A1 (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6656550B1 (en) * | 1996-10-08 | 2003-12-02 | Alan M. Zamore | Dilatation device of uniform outer diameter |
US7749585B2 (en) * | 1996-10-08 | 2010-07-06 | Alan Zamore | Reduced profile medical balloon element |
US6602224B1 (en) * | 1999-12-22 | 2003-08-05 | Advanced Cardiovascular Systems, Inc. | Medical device formed of ultrahigh molecular weight polyolefin |
US6428506B1 (en) * | 1999-12-22 | 2002-08-06 | Advanced Cardiovascular Systems, Inc. | Medical device formed of ultrahigh molecular weight polyethylene |
US6946174B1 (en) * | 2000-10-12 | 2005-09-20 | Boston Scientific Scimed, Inc. | Moisture curable balloon materials |
US6743388B2 (en) * | 2001-12-31 | 2004-06-01 | Advanced Cardiovascular Systems, Inc. | Process of making polymer articles |
US20040225213A1 (en) * | 2002-01-22 | 2004-11-11 | Xingwu Wang | Magnetic resonance imaging coated assembly |
US6846985B2 (en) | 2002-01-22 | 2005-01-25 | Nanoset, Llc | Magnetically shielded assembly |
US6946173B2 (en) * | 2002-03-21 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Catheter balloon formed of ePTFE and a diene polymer |
AU2002329810A1 (en) * | 2002-08-22 | 2004-03-29 | St. Jude Medical Atg, Inc. | High-strength balloon with tailored softness |
US20040039410A1 (en) * | 2002-08-22 | 2004-02-26 | Brooke Ren | High-strength balloon with tailored softness |
US20040115381A1 (en) * | 2002-12-12 | 2004-06-17 | Chevron Phillips Chemical Company, Lp | Method for manufacturing articles with materials containing tapered polymers |
JP2005128771A (ja) * | 2003-10-23 | 2005-05-19 | Fujitsu Ltd | データファイルシステム、データアクセスサーバ、およびデータアクセスプログラム |
US7659000B2 (en) * | 2004-04-12 | 2010-02-09 | Boston Scientific Scimed, Inc. | Adhesion technique for incompatible polymers using modified polymer tie layers |
US9492594B2 (en) * | 2014-07-18 | 2016-11-15 | M.A. Med Alliance SA | Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs |
US11406742B2 (en) | 2014-07-18 | 2022-08-09 | M.A. Med Alliance SA | Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs |
US9540475B2 (en) | 2015-03-12 | 2017-01-10 | Chevron Phillips Chemical Company Lp | Styrene-butadiene block copolymers for tubing applications |
US9441090B1 (en) | 2015-03-12 | 2016-09-13 | Chevron Phillips Chemical Company Lp | Methods for controlling hardness of styrene-butadiene block copolymers |
US9598524B1 (en) | 2015-09-18 | 2017-03-21 | Chevron Phillips Chemical Company Lp | Styrene-butadiene block copolymers with a terminal butadiene block for tubing applications |
US9738781B2 (en) | 2015-09-03 | 2017-08-22 | Ineos Styrolution Group Gmbh | Blends of styrene-butadiene block copolymer with styrenic thermoplastic elastomers for tubing applications |
US9828455B2 (en) | 2016-02-24 | 2017-11-28 | Ineos Styrolution Group Gmbh | Styrene-butadiene block copolymers with an internal butadiene block for tubing applications |
US10023676B2 (en) | 2016-02-24 | 2018-07-17 | Ineos Styrolution Group Gmbh | Styrene-butadiene block copolymers with an internal butadiene block for tubing applications |
US20180086905A1 (en) | 2016-09-26 | 2018-03-29 | Becton, Dickinson And Company | Enhancing Bond Strength Of Medical Devices |
US20180086902A1 (en) * | 2016-09-26 | 2018-03-29 | Becton, Dickinson And Company | Enhancing Bond Strength Of Medical Devices |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05300939A (ja) * | 1992-02-12 | 1993-11-16 | Daikyo Seiko:Kk | 医療用具品 |
JPH07118431A (ja) * | 1993-10-19 | 1995-05-09 | Mitsubishi Chem Corp | 通気性樹脂フィルム |
JPH07157508A (ja) * | 1993-02-22 | 1995-06-20 | Tosoh Corp | エチレン/α−オレフィン共重合体の製造方法 |
JPH08196620A (ja) * | 1995-01-27 | 1996-08-06 | Terumo Corp | 拡張用カテーテル及びその製造法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5478320A (en) * | 1989-11-29 | 1995-12-26 | Cordis Corporation | Puncture resistant balloon catheter and method of manufacturing |
GB9108242D0 (en) * | 1991-04-17 | 1991-06-05 | Exxon Chemical Patents Inc | Medical tubing |
DE69330107T3 (de) | 1992-02-12 | 2004-12-30 | Daikyo Gomu Seiko, Ltd. | Medizinisches Gerät |
CA2114697C (en) * | 1993-02-08 | 2006-06-13 | Kenichi Shimura | Medical tool having lubricious surface in a wetted state and method for production thereof |
US5670558A (en) * | 1994-07-07 | 1997-09-23 | Terumo Kabushiki Kaisha | Medical instruments that exhibit surface lubricity when wetted |
CA2170961C (en) * | 1995-03-22 | 2005-08-09 | Walter B. Mueller | Multilayer films for packaging and administering medical solutions |
WO1998022643A1 (en) * | 1996-11-22 | 1998-05-28 | Chisso Corporation | A non-woven fabric comprising filaments and an absorbent article using the same |
-
1997
- 1997-04-25 JP JP9123591A patent/JPH10295801A/ja active Pending
-
1998
- 1998-04-22 US US09/403,481 patent/US6238408B1/en not_active Expired - Fee Related
- 1998-04-22 WO PCT/JP1998/001838 patent/WO1998048863A1/ja not_active Application Discontinuation
- 1998-04-22 EP EP98917617A patent/EP0982040A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05300939A (ja) * | 1992-02-12 | 1993-11-16 | Daikyo Seiko:Kk | 医療用具品 |
JPH07157508A (ja) * | 1993-02-22 | 1995-06-20 | Tosoh Corp | エチレン/α−オレフィン共重合体の製造方法 |
JPH07118431A (ja) * | 1993-10-19 | 1995-05-09 | Mitsubishi Chem Corp | 通気性樹脂フィルム |
JPH08196620A (ja) * | 1995-01-27 | 1996-08-06 | Terumo Corp | 拡張用カテーテル及びその製造法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0982040A4 * |
Also Published As
Publication number | Publication date |
---|---|
US6238408B1 (en) | 2001-05-29 |
EP0982040A1 (en) | 2000-03-01 |
JPH10295801A (ja) | 1998-11-10 |
EP0982040A4 (en) | 2004-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998048863A1 (fr) | Sonde a ballonnet | |
US6881209B2 (en) | Medical device including unitary, continuous portion of varying durometer | |
EP0974370B1 (en) | Balloon for medical catheter | |
EP2186859B1 (en) | Tube and medical device comprising the same | |
KR100785562B1 (ko) | 프로필렌계 중합체 조성물 및 그의 용도 | |
US7485250B2 (en) | Medical device including improved expandable balloon | |
JP5079241B2 (ja) | 中空成形体の製造方法、積層中空成形体の製造方法、補強中空成形体の製造方法および補強積層中空成形体の製造方法 | |
KR20120108025A (ko) | 우수한 강성, 투명성 및 프로세싱 거동을 보이는 블로운 등급 | |
KR100909393B1 (ko) | 의료용 튜브 | |
WO2002100738A1 (en) | Duplex container | |
JP3579754B2 (ja) | 積層体及び医療用袋 | |
WO2001019425A1 (en) | Medical device including expandable balloon | |
EP3287488B1 (en) | Poly(1-butene) resin composition and molded object obtained therefrom | |
JP5908771B2 (ja) | 医療用チューブ | |
JP3270183B2 (ja) | バルーンカテーテル用バルーンおよびバルーンを備えたカテーテル | |
JP3729622B2 (ja) | 押出延伸ネット | |
JPH0975444A (ja) | 医療用基材 | |
WO2001005444A1 (fr) | Ballonnet pour catheter a ballonnet et procede de fabrication | |
JPH1033658A (ja) | 拡張用カテーテル及びその製造方法 | |
JP3471949B2 (ja) | 拡張用カテーテル及びその製造法 | |
JPH0947486A (ja) | 積層体及び医療用袋 | |
JPH0999036A (ja) | 医療用容器 | |
JP2001029448A (ja) | バルーンカテーテル用バルーン及びその製造方法 | |
EP0565448B1 (en) | Catheter shaft | |
JP3584556B2 (ja) | 医療用器具 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09403481 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998917617 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998917617 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998917617 Country of ref document: EP |